Malignant Uterine Neoplasm — Research

Malignant Uterine Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-13	4,773	`("Malignant Uterine Neoplasm"[tiab] OR "Uterine Cancer"[tiab] OR "Cancer of Uterus"[tiab] OR "Cancer of the Uterus"[tiab] OR "Malignant Uterine Tumor"[tiab] OR "Malignant Tumor of Uterus"[tiab] OR "Malignant Neoplasm of Uterus"[tiab] OR "Malignant Tumor of the Uterus"[tiab])`	2026-09-13	pubmed
Last 5 years	2021-01-01 → 2026-12-31	1,193	`("Malignant Uterine Neoplasm"[tiab] OR "Uterine Cancer"[tiab] OR "Cancer of Uterus"[tiab] OR "Cancer of the Uterus"[tiab] OR "Malignant Uterine Tumor"[tiab] OR "Malignant Tumor of Uterus"[tiab] OR "Malignant Neoplasm of Uterus"[tiab] OR "Malignant Tumor of the Uterus"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-13	pubmed
Last 12 months	2025-09-13 → 2026-09-13	219	`("Malignant Uterine Neoplasm"[tiab] OR "Uterine Cancer"[tiab] OR "Cancer of Uterus"[tiab] OR "Cancer of the Uterus"[tiab] OR "Malignant Uterine Tumor"[tiab] OR "Malignant Tumor of Uterus"[tiab] OR "Malignant Neoplasm of Uterus"[tiab] OR "Malignant Tumor of the Uterus"[tiab]) AND (2025/09/13:2026/09/13[dp])`	2026-09-13	pubmed

Data updated 18 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (141)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 101–125 of 141 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.
· Am J Obstet Gynecol · 2005 · PMID 15746676 · validated civic_curation pubmed
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study.
· J Clin Oncol · 2018 · PMID 29320312 · validated civic_curation pubmed
Olaparib in Patients With Solid Tumors With BRCA1/2 Alterations: Results From The Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
· JCO Precis Oncol · 2025 · PMID 41100773 · validated civic_curation pubmed